Clinical, virological, and antibody profiles of overlapping dengue and chikungunya virus infections in children from southern Colombia.

Clinical, virological, and antibody profiles of overlapping dengue and chikungunya virus infections in children from southern Colombia.

Publication date: Sep 08, 2025

Dengue and chikungunya are arboviral diseases with overlapping clinical characteristics. Dengue virus (DENV) is endemic in Colombia, and in 2014/2015, the chikungunya virus (CHIKV) caused an epidemic that resulted in over 350,000 cases. Since then, both viruses have been actively co-circulating. The early and accurate identification of pediatric infection caused by DENV or CHIKV is essential for proper medical management. Given that subsequent infections and co-infections with DENV and CHIKV have been reported, virological and immunological factors may influence their clinical outcomes. Here, we analyzed the viremia, antigenemia, and virus-specific antibody responses in hospitalized children suspected of having dengue during the peak of CHIKV infections in Colombia. Ninety-one children with a clinical diagnosis of dengue were included in the peak of the CHIKV epidemic (December 2014 to May 2015) at a reference healthcare center in Huila, south of Colombia. Multiplexed RT-qPCR for DENV, CHIKV, and ZIKV was performed, and DENV antigenemia was evaluated using an ELISA for the NS1 antigen. Commercial capture or in-house indirect NS1-based ELISAs were used to assess circulating DENV and CHIKV-IgM and IgG. Clinical and laboratory characteristics were analyzed during hospitalization, and convalescent follow-up was conducted for a fraction of children. DENV and CHIKV monoinfections were confirmed in 54% and 12% of children, respectively, with the expected virus-specific seroconversion in recovery. Overlapping infections occurred in 22% of the children, while 12% showed no detectable DENV or CHIKV infections. Abdominal pain, vomiting, hepatomegaly, and thrombocytopenia were common findings associated with DENV, while arthralgia and rash characterized CHIKV monoinfections. One fatal secondary DENV-3 monoinfection was registered, and DENV infection dominated the symptoms of overlapping infections without producing different clinical outcomes compared to monoinfections. Thirty-eight percent of children were seropositive for CHIKV-IgG, indicating a significant burden of CHIKV infection in the pediatric population shortly after its introduction in Colombia. The previous virus-specific IgG serostatus did not impact the clinical outcome of the current heterotypic arboviral infection. The pediatric population in southern Colombia was rapidly exposed to CHIKV infections during the first months following its arrival, with up to 12% of hospitalized children suspected of having dengue experiencing CHIKV monoinfection, supporting that complex and dynamic epidemiological patterns may lead to delayed or missed diagnoses. The overlapping infections of DENV and CHIKV were frequent and did not lead to worse clinical or fatal outcomes.

Open Access PDF

Concepts Keywords
Colombia Chikungunya
December Chikv
Hospitalization Children
Viruses Clinical
Colombia
Dengue
Denv
Igg
Infection
Infections
Outcomes
Overlapping
Pediatric
Specific
Virus

Semantics

Type Source Name
disease MESH dengue
disease MESH chikungunya virus infections
disease MESH infection
disease MESH co-infections
disease MESH viremia
disease MESH seroconversion
disease MESH hepatomegaly
disease MESH thrombocytopenia
disease MESH arthralgia
disease MESH missed diagnoses
disease MESH fatal outcomes
disease MESH Neglected Tropical Diseases
pathway REACTOME Reproduction
disease MESH mosquito borne diseases
disease MESH ZIKV infection
disease IDO country
disease MESH sequelae
disease MESH autochthonous transmission
disease IDO blood
disease IDO production
disease MESH syndrome
disease MESH severe dengue
disease IDO immune response
drug DRUGBANK Edetic Acid
disease MESH convalescence
disease IDO nucleic acid
disease IDO pathogen
drug DRUGBANK Ademetionine
drug DRUGBANK Coenzyme M
disease MESH tic
drug DRUGBANK Phosphate ion
drug DRUGBANK Biotin
pathway KEGG Virion
disease IDO symptom

Original Article

(Visited 8 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *